Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.

Abstract

Background A higher risk of developing dementia is observed in patients with atrial fibrillation (AF). Results are inconsistent regarding the risk of dementia when patients with AF use different anticoagulants. We aimed to investigate the risk of dementia in patients with AF receiving non-vitamin K antagonist oral anticoagulants (NOACs) compared with those receiving warfarin. Methods and Results We conducted a nationwide population-based cohort study of incident cases using the Taiwan National Health Insurance Research Database. We initially enlisted all incident cases of AF and then selected those treated with either NOACs or warfarin for at least 90 days between 2012 and 2016. First-ever diagnosis of dementia was the primary outcome. We performed propensity score matching to minimize the difference between each cohort. We used the Fine and Gray competing risk regression model to calculate the hazard ratio (HR) for dementia. We recruited 12 068 patients with AF (6034 patients in each cohort). The mean follow-up time was 3.27 and 3.08 years in the groups using NOACs and warfarin, respectively. Compared with the HR for the group using warfarin, the HR for dementia was 0.82 (95% CI, 0.73-0.92; P=0.0004) in the group using NOACs. Subgroup analysis demonstrated that users of NOAC aged 65 to 74 years, with a high risk of stroke or bleeding were associated with a lower risk of dementia than users of warfarin with similar characteristics. Conclusions Patients with AF using NOACs were associated with a lower risk of dementia than those using warfarin. Further randomized clinical trials are greatly needed to prove these findings.

• Authors: Jin-Yi Hsu, Peter Pin-Sung Liu, An-Bang Liu, Shu-Man Lin, Huei-Kai Huang, Ching-Hui Loh
• Journal: Journal of the American Heart Association (J Am Heart Assoc) Vol. 10 Issue 5 Pg. e016437 (02 2021) ISSN: 2047-9980 [Electronic] England
• PMID: 33586465 (Publication Type: Journal Article, Multicenter Study)

Chemical References

• Anticoagulants
• Warfarin

Topics

• Administration, Oral
• Aged
• Anticoagulants (administration & dosage)
• Atrial Fibrillation (complications, drug therapy, epidemiology)
• Dementia (epidemiology, etiology, prevention & control)
• Female
• Follow-Up Studies
• Humans
• Incidence
• Male
• Population Surveillance
• Retrospective Studies
• Risk Assessment (methods)
• Risk Factors
• Stroke (complications, prevention & control)
• Survival Rate (trends)
• Taiwan
• Warfarin (administration & dosage)